Holding(s) in Company
SkinBioTherapeutics plc has announced a major holding notification where Mark H Dixon and Diana Dixon, through Rock Nominees Limited, have increased their voting rights to 28.359%, representing 73,500,000 voting rights. This acquisition of voting rights occurred on July 17, 2026, and the previous notification showed a holding of 26.971%, representing 69,900,000 voting rights. The notification was made on July 20, 2026, and the individuals are not controlled by any other entity.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Mark H Dixon and Diana Dixon |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
| Name | Rock Nominees Limited |
| City and country of registered office (if applicable) | London, UK |
| 5. Date on which the threshold was crossed or reached vi : | 17/07/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 20/07/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 28.359% | 28.359% | 73,500,000 |
| Position of previous notification (if applicable) | 26.971% | 26.971% | 69,900,00 |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| Ordinary shares GB00BF33H870 | 73,500,000 | 28.359% | |
| SUBTOTAL 8. A | 73,500,000 | 28.359% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
| Name of the proxy holder | N/A |
| The number and % of voting rights held | N/A |
| The date until which the voting rights will be held | N/A |
| 11. Additional information xvi | |
| Place of completion | London |
| Date of completion | 20 July 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.